Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China

被引：0
作者：
C. Hutchison
M. S. Khan
J. Yoong
X. Lin
R. J. Coker
机构：
[1] London School of Hygiene and Tropical Medicine,Saw Swee Hock School of Public Health
[2] National University of Singapore,Centre for Economic and Social Research
[3] University of Southern California,Faculty of Public Health
[4] Yunnan Center for Disease Control and Prevention,undefined
[5] Mahidol University,undefined
来源：
BMC Public Health | / 17卷
关键词：
Tuberculosis; Multidrug-resistance; China; Barriers; Qualitative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment
    Seddon, James A.
    Johnson, Sarah
    Palmer, Megan
    van Der Zalm, Marieke M.
    Lopez-Varela, Elisa
    Hughes, Jennifer
    Schaaf, H. Simon
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (02) : 221 - 237
  • [22] Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
    Alene, Kefyalew Addis
    Yi, Hengzhong
    Viney, Kerri
    McBryde, Emma S.
    Yang, Kunyun
    Bai, Liqiong
    Gray, Darren J.
    Clements, Archie C. A.
    Xu, Zuhui
    BMC INFECTIOUS DISEASES, 2017, 17
  • [23] Tuberculosis treatment interruption: a qualitative exploration of barriers, challenges, coping strategies and facilitators in Malaysia
    Oh, Ai Ling
    Makmor-Bakry, Mohd
    Islahudin, Farida
    Ting, Chuo Yew
    Chan, Swee Kim
    Tie, Siew Teck
    HEALTH PROMOTION INTERNATIONAL, 2024, 39 (06)
  • [24] Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
    Tang, Shenjie
    Yao, Lan
    Hao, Xiaohui
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi?an China, a Retrospective Cohort Study
    Ma, Jin-Bao
    Zeng, Ling-Cheng
    Ren, Fei
    Dang, Li-Yun
    Luo, Hui
    Wu, Yan-Qin
    Yang, Xin-Jun
    Li, Rong
    Yang, Han
    Xu, You
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4947 - 4957
  • [26] Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study
    Hu, Yi
    Zheng, Xubin
    Forsman, Lina Davies
    Ning, Zhu
    Chen, Cheng
    Gao, Yazhou
    Zhang, Zhengdong
    Lu, Wei
    Werngren, Jim
    Bruchfeld, Judith
    Hoffner, Sven
    Xu, Biao
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1805 - 1813
  • [27] High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China
    Chen, Ling
    Li, Nana
    Liu, Mei
    Zhang, Jianyong
    Zhang, Hong
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) : 2435 - 2437
  • [28] Risk factors of multidrug-resistant tuberculosis in China: A meta-analysis
    Feng, Mei
    Xu, YuanGao
    Zhang, XiangYan
    Qiu, Qian
    Lei, ShiGuang
    Li, JinLan
    Yuan, Wei
    Song, QunFeng
    Xu, JinHong
    PUBLIC HEALTH NURSING, 2019, 36 (03) : 257 - 269
  • [29] Risk factors for multidrug-resistant tuberculosis: a predictive model study
    Wu, Lianpeng
    Cai, Xiaoxiao
    Jiang, Xiangao
    FRONTIERS IN MEDICINE, 2024, 11
  • [30] The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
    Weerasuriya, Chathika K.
    Harris, Rebecca C.
    McQuaid, C. Finn
    Bozzani, Fiammetta
    Ruan, Yunzhou
    Li, Renzhong
    Li, Tao
    Rade, Kirankumar
    Rao, Raghuram
    Ginsberg, Ann M.
    Gomez, Gabriela B.
    White, Richard G.
    BMC MEDICINE, 2021, 19 (01)
12345